Related Experiment Video
Updated: Feb 7, 2026

Reprogramming Human Somatic Cells into Induced Pluripotent Stem Cells iPSCs Using Retroviral Vector with GFP
Published on: April 3, 2012
NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC
Thach Mai1,2, Glenn J Markov1,2, Jennifer J Brady1,2,3
1Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Abstract:
Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) is now routinely accomplished by overexpression of the four Yamanaka factors (OCT4, SOX2, KLF4, MYC (or OSKM))1. These iPSCs can be derived from patients' somatic cells and differentiated toward diverse fates, serving as a resource for basic and translational research. However, mechanistic insights into regulators and pathways that initiate the pluripotency network remain to be resolved. In particular, naturally occurring molecules that activate endogenous OCT4 and replace exogenous OCT4 in human iPSC reprogramming have yet to be found. Using a heterokaryon reprogramming system we identified NKX3-1 as an early and transiently expressed homeobox transcription factor. Following knockdown of NKX3-1, iPSC reprogramming is abrogated. NKX3-1 functions downstream of the IL-6-STAT3 regulatory network to activate endogenous OCT4. Importantly, NKX3-1 substitutes for exogenous OCT4 to reprogram both mouse and human fibroblasts at comparable efficiencies and generate fully pluripotent stem cells. Our findings establish an essential role for NKX3-1, a prostate-specific tumour suppressor, in iPSC reprogramming.
Insights
NKX3-1, a tumor suppressor, can replace Yamanaka factors for induced pluripotent stem cell (iPSC) generation. This discovery offers new avenues for iPSC reprogramming and regenerative medicine research.
Area of Science:
- Stem cell biology
- Molecular biology
- Cancer research
Background:
- Induced pluripotent stem cells (iPSCs) are generated using Yamanaka factors (OCT4, SOX2, KLF4, MYC).
- Mechanisms initiating pluripotency networks and natural activators of endogenous OCT4 remain unclear.
- Identifying novel factors for iPSC reprogramming is crucial for advancing regenerative medicine.
Purpose of the Study:
- To identify novel regulators of endogenous OCT4 activation in iPSC reprogramming.
- To investigate the role of NKX3-1 in the pluripotency network.
- To determine if NKX3-1 can substitute for exogenous OCT4 in iPSC generation.
Main Methods:
- Utilized a heterokaryon reprogramming system.
- Performed NKX3-1 knockdown experiments.
- Assessed iPSC generation efficiency and pluripotency markers.
Main Results:
- Identified NKX3-1 as an early, transiently expressed homeobox transcription factor essential for iPSC reprogramming.
- NKX3-1 functions downstream of the IL-6-STAT3 pathway to activate endogenous OCT4.
- NKX3-1 successfully replaced exogenous OCT4 in reprogramming mouse and human fibroblasts with high efficiency.
Conclusions:
- NKX3-1 plays a critical role in initiating the pluripotency network by activating endogenous OCT4.
- NKX3-1 can serve as a functional substitute for exogenous OCT4 in iPSC reprogramming.
- These findings highlight NKX3-1, a prostate-specific tumor suppressor, as a key factor in iPSC generation.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Embryonic Stem Cells
Adult Stem Cells
Somatic to iPS Cell Reprogramming

